Follow The Filings

HQY Healthequity Inc.

Health Care, filed as HEALTHEQUITY INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q3

  • 1 Owner
  • Max 0.1%
  • $62M
  • 1 reduce

In 2026 Q3 Ron Baron trimmed Healthequity.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Ron Baron, BAMCO Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Reduce 0.10%

Who owns HQY

Sorted by value, long equity only, as of 2026 Q3.

History
Ron Baron, BAMCO Inc. (Baron Capital) 0.10% Reduce −6.7% 700,394 $62M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by HQY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HQY insider trades
  • $12K bought by 1 insider
  • $1.5M sold by 3 insiders outside a trading plan
  • $2.6M sold by 4 insiders under 10b5-1 plans
  1. Sunil Rajasekar EVP Chief Prod & Strat Officer
    Buy
    $12K 131 shares at $91.16 +0.2% to stake
    Traded Jul 8–Oct 15 Filed Oct 19
  2. Sunil Rajasekar EVP Chief Prod & Strat Officer
    Sale
    $13K 131 shares at $101.60 0.2% of stake
    Traded Apr 22–Aug 24 Filed Oct 19
  3. Adrian T. Dillon Director
    Planned sale
    $798K 7,632 shares at $104.61 11% of stake
    Traded Aug 25 Filed Aug 27
  4. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $224K 2,354 shares at $95.00 4.3% of stake
    Traded Jul 10 Filed Jul 14
  5. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $235K 2,470 shares at $95.00 4.2% of stake
    Traded Jul 2 Filed Jul 7
  6. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $298K 3,142 shares at $95.00 5% of stake
    Traded May 29 Filed Jun 2
  7. Gayle Furgurson Wellborn Director
    Planned sale
    $220K 2,439 shares at $90.00 11% of stake
    Traded May 28 Filed Jun 1
  8. Delano Ladd EVP, General Counsel
    Planned sale
    $675K 7,500 shares at $90.00 7.6% of stake
    Traded May 28 Filed Jun 1
  9. Delano Ladd EVP, General Counsel
    Planned sale
    $142K 1,500 shares at $94.72 2% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
  10. Elimelech Rosner EVP, Chief Technology Officer
    Sale
    $1M 10,959 shares at $95.45 19% of stake
    Traded Dec 18, 2025 Filed Dec 19, 2025
  11. Gayle Furgurson Wellborn Director
    Sale
    $425K 4,339 shares at $98.03 18% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
  12. Delano Ladd EVP, General Counsel
    Planned sale
    $157K 1,500 shares at $104.56 1.9% of stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  13. Delano Ladd EVP, General Counsel
    Planned sale
    $138K 1,500 shares at $92.07 1.9% of stake
    Traded Oct 20, 2025 Filed Oct 22, 2025
  14. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $157K 1,781 shares at $88.21 3.5% of stake
    Traded Oct 7, 2025 Filed Oct 8, 2025

Also filed in the last 12 months, not counted as buying or selling: 27 share withholdings for taxes, 20 stock grants, 4 gifts, and 3 option exercises.

Congress

5 members of Congress traded HQY in the last three years: 4 buys and 7 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jul 10 filed Sep 4
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jun 30 filed Jul 2
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 29 filed Jun 8
  4. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  5. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 11, 2025 filed Aug 13, 2025
  6. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Jun 16, 2025 filed Jul 10, 2025

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 5.02
8-K 5.02,7.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.07,9.01
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $0.862B $1B $1.2B $1.31B
Gross profit $490.09M $622.64M $777.26M $913.12M
Gross margin * 56.9% 62.3% 64.8% 69.5%
Net income -$26.14M $55.71M $96.7M $215.2M
Net margin * -3.0% 5.6% 8.1% 16.4%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $382.89M $557.44M $477.75M $512.28M
Total non-current assets * $2.71B $2.61B $2.97B $2.87B
Total assets $3.09B $3.16B $3.45B $3.38B
Total current liabilities $131.06M $117.09M $156.32M $156.85M
Total non-current liabilities $1.06B $1.01B $1.18B $1.12B
Total equity $1.9B $2.04B $2.11B $2.11B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $150.65M $242.83M $339.86M $457.09M
Cash from investing -$119.13M -$46.07M -$505.45M -$47.14M
Cash from financing -$2.67M -$47.04M $57.57M -$386.98M
Net change in cash $28.85M $149.71M -$108.03M $22.98M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf